BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Spinogenix Announces Launch of a Phase 2 Clinical Trial Evaluating SPG302 for the Treatment of Schizophrenia

  September 25, 2024

   · 

  5 min read
• Press Releases

  INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society

  --Data will be presented at the conference in October in Montreal

  September 25, 2024

   · 

  3 min read
• FDA

  EydisBio Receives FDA Orphan Drug Designation for TAK1 Inhibitor for the Treatment of Systemic Sclerosis

  September 25, 2024

   · 

  3 min read
• Business

  Actio Biosciences to Participate in Upcoming October Investor Conferences

  September 25, 2024

   · 

  1 min read
• Business

  Abbott Hosts Conference Call for Third-Quarter Earnings

  September 25, 2024

   · 

  1 min read
• News

  LEO Pharma Presents Late-Breaking Anzupgo® (delgocitinib) Cream Presentation at EADV 2024 Highlighting Results of Head-to-Head DELTA FORCE Trial in Chronic Hand Eczema (CHE)

  September 25, 2024

   · 

  15 min read
• Business

  Ocular Therapeutix™ to Present at the UBS Virtual Ophthalmology Day 2024

  September 25, 2024

   · 

  1 min read
• Press Releases

  Multiple Sclerosis Therapeutic Market Size to Hit USD 46.44 Bn by 2033

  September 25, 2024

   · 

  10 min read
• Press Releases

  Freenome Announces CEO Transition

  September 25, 2024

   · 

  2 min read
• News

  Enveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug Summit

  September 25, 2024

   · 

  5 min read